Impact of Toxicity Grade and Scoring System on the Relationship Between Mean Lung Dose and Risk of Radiation Pneumonitis in a Large Cohort of Patients With Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 3, 2010, Pages 691-698

  Tucker, Susan L ^a   Jin, Hekun ^b   Wei, Xiong ^a   Wang, Shulian ^c   Martel, Mary K ^a   Komaki, Ritsuko ^a   Liu, H Helen ^a   Mohan, Radhe ^a   Chen, Yuhchyau ^d   Cox, James D ^a   Liao, Zhongxing ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b HUNAN CANCER HOSPITAL   (China)

^c CANCER HOSPITAL   (China)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Lung cancer; Mean lung dose; Radiation pneumonitis; Toxicity scoring systems

Indexed keywords

ADVERSE EVENTS; COMMON TERMINOLOGY CRITERIA; DEFINITIVE RADIOTHERAPY; GRADING SYSTEM; LOG-LOGISTIC; LUNG CANCER; MEAN LUNG DOSE; MEDICAL RECORD; MODEL FIT; NATIONAL CANCER INSTITUTE; NON SMALL CELL LUNG CANCER; NORMAL-TISSUE COMPLICATION PROBABILITY MODELS; PARAMETER ESTIMATE; QUANTITATIVE COMPARISON; RADIATION PNEUMONITIS; RADIATION THERAPY ONCOLOGY GROUPS; RADIOGRAPHIC IMAGES; SCORING SYSTEMS; THRESHOLD LEVELS;

BIOLOGICAL ORGANS; RISKS; TOXICITY;

RADIOTHERAPY;

ARTICLE; CANCER PATIENT; COHORT ANALYSIS; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE; RADIATION HAZARD; RADIATION INJURY; RADIATION PNEUMONIA; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL MODEL; TOXICITY TESTING;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; FOLLOW-UP STUDIES; HUMANS; LUNG; LUNG NEOPLASMS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RISK ASSESSMENT; TIME FACTORS;

EID: 77952641781     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.055     Document Type: Article

References (37)

1. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys 28 (1994) 575-581
2. Oetzel D., Schraube P., Hensley F., et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 33 (1995) 455-460
3. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
4. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
5. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
6. Lind P.A., Marks L.B., Hollis D., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54 (2002) 340-347
7. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
8. Jenkins P., D'Amico K., Benstead K., et al. Radiation pneumonitis following treatment of non-small-cell lung cancer with continuous hyperfractionated accelerated radiotherapy (CHART). Int J Radiat Oncol Biol Phys 56 (2003) 360-366
9. Moiseenko V., Craig T., Bezjak A., et al. Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: A retrospective review. Radiother Oncol 67 (2003) 265-274
10. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
11. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
12. Willner J., Jost A., Baier K., et al. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy. Strahlenther Onkol 179 (2003) 548-556
13. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: A Phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
14. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
15. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
16. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
17. Hope A.J., Lindsay P.E., El Naqa I., et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 65 (2006) 112-124
18. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 (2006) 1075-1086
19. Wang S., Liao Z., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 (2006) 1399-1407
20. Bradley J.D., Hope A., El Naqa I., et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 69 (2007) 985-992
21. Rancati T., Wennberg B., Lind P., et al. Early clinical and radiological pulmonary complications following breast cancer radiation therapy: NTCP fit with four different models. Radiother Oncol 82 (2007) 308-316
22. Schallenkamp J.M., Miller R.C., Brinkmann D.H., et al. Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates. Int J Radiat Oncol Biol Phys 67 (2007) 410-416
23. Cancer Therapy Evaluation Program. Available at http://ctep.cancer.gov/reporting/ctc.html.
24. Green S., and Weiss G.R. Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 10 (1992) 239-253
25. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
26. Eastern Cooperative Oncology Group. ECOG Common Toxicity Criteria. Available at http://ecog.dfci.harvard.edu/general/common_tox.html.
27. World Health Organization Handbook for Reporting Results of Cancer Treatment. Geneva S, WHO Offset Publication No. 48, 1979.
28. Pavy J.J., Denekamp J., Letschert J., et al. EORTC Late Effects Working Group. Late effects toxicity scoring: The SOMA scale. Radiother Oncol 35 (1995) 11-15
29. Jin H., Tucker S.L., Liu H.H., et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 91 (2009) 427-432
30. Tucker S.L., Liu H.H., Liao Z., et al. Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys 72 (2008) 568-574
31. Morgan B.J.T. Analysis of quantal response data (1992), Chapman & Hall, New York
32. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
33. Bentzen S.M., and Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71 (1997) 531-542
34. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 23 (1984) 379-391
35. Claude L., Perol D., Ginestat C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
36. Monson J.M., Stark P., Reilly J.J., et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer 82 (1998) 842-850
37. Wang S., Liao Z., Wei X., et al. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. J Thorac Oncol 3 (2008) 277-282